Cart
sales@molnova.com
[Tyr8] Substance P
CAS No. 55614-10-3
[Tyr8] Substance P( ——— )
Catalog No. M41619 CAS No. 55614-10-3
[Tyr8]-Substance P is an active peptide. [Tyr8]-Substance P can be used for the research of various biochemical.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
Biological Information
-
Product Name[Tyr8] Substance P
-
NoteResearch use only, not for human use.
-
Brief Description[Tyr8]-Substance P is an active peptide. [Tyr8]-Substance P can be used for the research of various biochemical.
-
Description[Tyr8]-Substance P is an active peptide. [Tyr8]-Substance P can be used for the research of various biochemical.
-
In Vitro[Tyr8]-Substance P at a very high dosage released LH and FSH in vitro.
-
In Vivo[Tyr8]-Substance P shows the activity in contraction of the isolated guinea pig ileum and decrease in systemic blood pressure of dogs.
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number55614-10-3
-
Formula Weight1363.66
-
Molecular FormulaC63H98N18O14S
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Fisher, et al. Hypothalamic hormones. 71. Synthesis and some biological activities of the tyrosine-8 analog of substance P. Journal of Medicinal Chemistry.Volume: 19. Issue: 2. Pages: 325-8. Journal; Article. 1976.
molnova catalog
related products
-
resorufin galactopyr...
resorufin galactopyranoside is a chemical compound.
-
Columbamine
Columbamine exerts anti-proliferative and anti-vasculogenic effects on metastatic human osteosarcoma U2OS cells with low toxicity.
-
GSK-3 inhibitor 3
GSK-3 inhibitor 3 is a selective, orally active, brain-permeable GSK-3 inhibitor that inhibits GSK-3α and GSK-3β with IC50s of 0.35 nM and 0.25 nM, respectively.
